ICVX Chart
See on advanced chart >
About
Icosavax, Inc. was incorporated in the state of Delaware on November 1, 2017, and is located in Seattle, Washington. The Company is a biopharmaceutical company leveraging innovative virus-like particle (VLP) platform technology to develop vaccines against...
Read More
- HighlightA biopharmaceutical company that develops vaccines against infectious diseases
- ExchangeNASDAQ
- Listing Date07/29/2021
- Established Date11/01/2017
- Full-time Employees60
- Address1930 Boren Avenue Suite 1000 Seattle Washington 98101
- Tel1-206-7370085
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry